-
PSYCHOMETRIC VALIDATION OF THE QLQ-AA/PNH-54 BASED ON A POOLED DATASET OF A CLINICAL TRIAL AND TWO REAL-WORLD STUDIES OF CROVALIMAB IN PARTICIPANTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Mar 18, 2026, 21:38 PM -
EVOLUTION OF FDA COMPANION DIAGNOSTICS
Mar 18, 2026, 21:38 PM -
COST ANALYSIS AND HEALTHCARE RESOURCE UTILIZATION AFTER OPEN LIVER RESECTION FROM A RANDOMIZED CONTROL TRIAL
Mar 18, 2026, 21:38 PM -
LONG-TERM OUTCOMES OF FIBROMYALGIA PATIENTS WITH AND WITHOUT INSOMNIA: A REAL-WORLD COHORT STUDY
Mar 18, 2026, 21:38 PM -
A LANDSCAPE ASSESSMENT OF THE STATISTICAL AND ECONOMIC MODELING OF CURE IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS OF FIRSEKIBART FOR THE TREATMENT OF ACUTE GOUT PATIENTS UNSUITABLE FOR STANDARD THERAPY IN CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF NOVEL ANDROGEN RECEPTOR INHIBITORS IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER: A U.S. ANALYSIS INCORPORATING TWO-WAY SENSITIVITY ASSESSMENT
Mar 18, 2026, 21:38 PM -
UNDERSTANDING PRIORITIES IN HEALTH ECONOMICS: MAPPING COST-EFFECTIVENESS AND DISEASE BURDEN TRENDS
Mar 18, 2026, 21:38 PM -
QUANTIFYING CDA-INESSS DIFFERENCES IN ONCOLOGY HTA: RECOMMENDATIONS, RE-ANALYSIS, AND PRICE REDUCTIONS (2024-2025)
Mar 18, 2026, 21:38 PM -
COST OF CARE AND BUDGET IMPACT OF NOVEL FIRST-LINE (1L) TREATMENTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN COSTA RICA
Mar 18, 2026, 21:38 PM -
RAPID AI-ENABLED PICO SCOPING TO SUPPORT EUROPEAN JOINT CLINICAL ASSESSMENTS: A 4TH-LINE METASTATIC COLORECTAL CANCER CASE STUDY
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
ANTI-OSTEOPOROSIS DRUGS PRESCRIPTIONS AMONG OSTEOPOROSIS PATIENTS WITH T2DM IN CHINA
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PICO REVIEW AND HIERARCHY IN SYSTEMATIC LITERATURE REVIEWS: WHY GUIDELINE ADHERENCE MATTERS AND HOW REAL-SLRS REDUCE REWORK
Mar 18, 2026, 21:38 PM -
DO MULTIPLE PRESENTATIONS AFFECT THE DURATION OF U.S. DRUG SHORTAGES?
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
ASSESSING THE VALUE OF LOST SCHOOLING DUE TO ILLNESS AMONG CHILDREN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
FROM FEASIBILITY TO FINDINGS: SUPPORTING INDIRECT TREATMENT COMPARISONS WITH GENERATIVE AI
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
A MODULAR ONCOLOGY REFERENCE MODEL FOR EARLY ECONOMIC EVALUATION: A CASE STUDY IN EGFR-MUTATED NSCLC
Mar 18, 2026, 21:38 PM